Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of a Single Dose of Gallium [68Ga]-NYM032 Injection Prepared by Kit for the Preparation of the 68Ga-NYM032 Injection in Patients With Prostate Cancer
Latest Information Update: 28 May 2025
At a glance
- Drugs Gallium 68 NY 108 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Norroy Bioscience
Most Recent Events
- 06 May 2024 New trial record